FDA lifts hold on No­vavax vac­cines af­ter ad­verse event re­clas­si­fied as ALS

The FDA has re­moved a clin­i­cal hold on No­vavax’s flu-Covid com­bi­na­tion shot and stand­alone flu vac­cine, less than a month af­ter

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.